Abstract:Vascular and Endovascular Surgery, Ahead of Print. ObjectiveThis systematic review and network meta-analysis aimed to evaluate the efficacy and safety of direct oral anticoagulants (DOACs) in adults aged 75 and over undergoing acute venous thromboembolism (VTE) treatment.MethodsPubMed, Embase and the CENTRAL were searched up to 25 December 2023. The incidence of VTE recurrence and bleeding events was assessed. Employing a frequentist network meta-analysis approach, interventions not directly compared could be indirectly assessed through the 95% confidence interval (CI), enhancing the interpretability of the search results. The surface under the cumulative ranking curves (SUCRA) was utilized to generate the relative ranking probabilities for each group.ResultsOur study, analysing 6 randomised controlled trials with 3665 patients, compares direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in adults aged 75 and over with acute venous thromboembolism. Edoxaban reduces VTE recurrence risk compared with VKAs (risk ratio [RR] .50, 95% CI 0.27 – .95), while apixaban significantly decreases bleeding risk compared with VKAs (RR .23, 95% CI 0.08 – .69), edoxaban (RR .28, 95% CI 0.09 – .86) and rivaroxaban (RR .28, 95% CI 0.09 – .86). Despite low overall evidence quality, apixaban consistently ranks highest for both efficacy and safety. Findings underscore the nuanced efficacy-safety balance in this population, emphasizing cautious interpretation due to evidence limitations.ConclusionApixaban emerges as a favourable choice for acute VTE treatment in the elderly, displaying reduced bleeding risk compared to other treatments while maintaining comparable efficacy. Future studies should explore diverse anticoagulants efficacy and safety in older populations. Additionally, clinical prediction models tailored to geriatric cohorts are crucial for guiding treatment duration decisions.

Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants

Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis

Direct oral anticoagulants in patients with VTE and cancer

Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension

Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials

Meta-Analysis of the Safety and Efficacy of Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review

Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer

Direct Oral Anticoagulants for Pulmonary Embolism

[Direct oral anticoagulant for venous thrombosis in unusual sites]

Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients

Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis

Efficacy and Safety of Direct Oral Anticoagulants in Cerebral Venous Thrombosis: Meta-Analysis of Randomized Clinical Trials

The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment

Comparison of direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for venous thromboprophylaxis after radical cystectomy: A systematic review and meta-analysis

Efficacy and Safety of Direct Oral Anticoagulants for Acute Treatment of Venous Thromboembolism in Older Adults: A Network Meta-Analysis of Randomised Controlled Trials

Direct oral anticoagulant therapy in adolescent venous thromboembolism: A systematic review

Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis